The groundbreaking rise of Viagra has firmly established as a symbol of pharmaceutical success, but its position within the broader market now triggers questions about long-term yields . Alternative versions are diminishing exclusivity , prompting concerns that betting on companies significantly dependent to Viagra's former standing could be a prob